Pivot Bio Valuation Estimate
Pivot Bio Valuation as of Last Funding Round
Pivot Bio Company Overview
Pivot Bio creates microbial nitrogen solutions for row crops. Its engineered microbes live on plant roots and convert atmospheric nitrogen into a form crops can use, supplying nitrogen steadily through the growing season. The product line includes on-seed and in-furrow options for corn, wheat, sorghum and other cereals, helping farmers replace part of synthetic fertilizer and reduce nitrous oxide emissions and runoff. The company distributes through agricultural retailers and direct grower programs, and supports adoption with agronomic services and performance data from field trials and on-farm use. Pivot Bio operates U.S.-based fermentation and production facilities to scale manufacturing and aims to improve nitrogen efficiency, yields, and nutrient management while simplifying application logistics for growers.
Pivot Bio Valuation History
New to Pre-IPO Investing?
Get smarter about private markets and Pre-IPO investing:
- Get key practice tips for private-market investing
- Understand how to evaluate deal terms and common structures
- Evaluate fees and their impact on returns
- Develop a thesis and underwrite your investment
- Learn common pitfalls first-time investors face
FAQ
Does Pivot Bio have stock?
Yes, Pivot Bio and almost all privately held companies issue stock so founders, employees, and investors can participate in equity ownership. However, because Pivot Bio is privately held, it is more challenging to acquire shares than if the company was publicly traded.
Is Pivot Bio publicly traded?
No, Pivot Bio is a privately held company. It is not publicly traded or offered directly on any stock exchange like the NYSE, Nasdaq, etc.
Who owns Pivot Bio stock?
As a privately held company, Pivot Bio shares are held by its founders, management, employees, venture
capital funds, or other private individuals and institutional investors.
Disclosure rules differ for private and public companies, so it may not always be possible to know the
complete ownership (cap table) of a private company like Pivot Bio.
What is the stock symbol for Pivot Bio?
Pivot Bio is a privately held company. Therefore, it does not have a stock symbol or “ticker” that trades on public exchanges like the NYSE, Nasdaq, etc.
Can I buy Pivot Bio shares on UpMarket?
If you would like to buy shares in Pivot Bio, please provide your information in the form at the top of this page and click the button titled
“I want to buy this stock.”
One of our investor relations team members will contact you to discuss Pivot Bio stock availability.
Note: inquiries are non-binding, subject to market availability, and shares may only be purchased by accredited investors that meet all
eligibility criteria.
UpMarket has offered many similar companies as Pre-IPO investments, including Airbnb, SpaceX, ByteDance,
Plaid, Kraken, Databricks, and others. UpMarket also often has funds available that invest in a portfolio of companies potentially including,
Pivot Bio as well.
What is Pivot Bio stock price?
The stock price of Pivot Bio can be calculated by taking the valuation of the company divided by the
number of shares outstanding. Because a private company can issue new shares at any time, we do not know the
current number of shares outstanding.
For illustrative purposes, however, assuming Pivot Bio has issued 250 million shares, at the estimated
UpMarket valuation of $2.21 billion, each share of Pivot Bio stock
would be worth $8.82.
How do Pivot Bio pre-IPO trades work?
Pre-IPO trades for Pivot Bio will typically involve accredited investors purchasing shares from current
shareholders through specialized investment platforms like UpMarket. Trades generally occur on the secondary market, meaning Pivot Bio doesn't
issue new shares or receive capital–shares are privately exchanged between two parties.
While investors aim to profit from a potential IPO or acquisition, these investments carry high risks due to
limited liquidity and information. Understanding all terms and conditions is crucial, as each transaction can
have unique characteristics. Investing in private companies can be extremely risky and may result in
significant capital loss.
When is Pivot Bio going to go public?
The decision to go public through an Initial Public Offering (IPO) is complex and depends on various factors,
including the company's financial performance, market conditions, and strategic goals.
Unless Pivot Bio officially announces its intention to go public, any predictions about when or if it
will do so would be speculative.
Investors interested in Pivot Bio should monitor official company communications and reliable financial
news sources for any updates regarding potential IPO plans.
How do I exit my investment if I invest in Pivot Bio with UpMarket?
Exiting your investment in Pivot Bio typically involves one of these scenarios: 1) selling your shares
on a secondary market to other interested investors; 2) holding shares until a liquidity event occurs, such as
the company going public (IPO) or being acquired.
Investors must know that the timing and availability of these exit options are inherently unpredictable, and
there is no guarantee of when or if they will occur.
How can I sell Pivot Bio shares?
If you own Pivot Bio shares, you may be able to find a buyer on a pre-IPO marketplace or via an introduction by a registered broker-dealer like UpMarket. It is important to note that the class of shares you own may impact your ability to sell. For example, shares issued to startup employees often have transaction limitations, including lock-up periods and a right of first refusal by the company, which may prevent you from selling your shares freely.
How does UpMarket estimate the valuation of Pivot Bio?
UpMarket’s valuation estimate for Pivot Bio is algorithmically generated based on recent primary round
financings by Pivot Bio, market conditions, company popularity, sector performance, and public market
comps.
It is important to note that UpMarket’s valuation estimate for Pivot Bio could be outdated, may not
reflect all recent news or market events, and is not intended to inform any investment decision-making.
UpMarket’s valuation estimate is not meant to be a warranty or projection of potential financial returns or
company performance. Valuations can change rapidly and unexpectedly.
Why choose UpMarket?
Founded in 2019, UpMarket has brokered over $1.3 billion in alternative investments for more than 1300+
investors, including principal invested and appreciation as of March 31, 2026. These investments span pre-IPO
companies, hedge funds, private equity, real estate, and other alternative assets. Approximately $301 million
is managed by UpMarket Management, with the remainder managed by affiliates. Past performance is not
predictive of future results. UpMarket is a licensed broker-dealer based in the United States.
If you are an accredited investor, you can create a
free account to access our deal flow and
opportunities. There is never any pressure to invest.
UpMarket clients have invested in companies like
Pivot Bio,
Anduril, Perplexity, Neuralink, and many others. UpMarket and its leadership have been mentioned in media
outlets like Forbes,
WealthManagement,
Wealth
and Finance News, and TechBullion.
Pivot Bio Management
| Name | Position |
|---|---|
| Karsten Temme | CEO |
